Klaviyo, INC Form 4 insider transactions

Roxanne Oulman, a Director of Klaviyo, Inc., reported multiple transactions in common stock on July 22, 2026.

Amanda Whalen, Chief Financial Officer of Klaviyo, Inc., sold 14,000 shares of common stock on July 16, 2026 for $17.75 per share.

Klaviyo's Chief Financial Officer, Amanda Whalen, has sold a significant number of Series A Common Stock shares as part of a pre-arranged trading plan.

Director Roxanne Oulman acquired 14,822 restricted stock units and converted 8,169 shares of Series B common stock to Series A.

Director Susan St. Ledger was granted 14,822 restricted stock units as part of the company's 2023 equity incentive plan.

Director Jennifer Ceran was granted 14,822 restricted stock units as part of the company's 2023 Stock Option and Incentive Plan.

Klaviyo director Tony Weisman was granted 14,822 restricted stock units as part of the company's 2023 incentive plan.

Klaviyo Co-CEO Luciano Fernandez Gomez disposed of 1,746 shares to satisfy tax obligations related to RSU vesting.

Klaviyo Co-CEO Andrew Bialecki sold 212,529 shares of Series A Common Stock via a pre-arranged Rule 10b5-1 trading plan.

Klaviyo Director Susan St. Ledger executed a planned sale of 9,334 shares of Series A Common Stock.

Klaviyo Co-CEO Andrew Bialecki sold 200,000 shares of Series A Common Stock via a pre-arranged Rule 10b5-1 trading plan.

Klaviyo Chief Legal Officer Landon Edmond disposed of 22,340 shares to satisfy tax obligations related to RSU vesting.

Klaviyo Co-CEO Luciano Fernandez Gomez disposed of 22,132 shares to satisfy tax obligations related to RSU vesting.

Klaviyo Chief People Officer Carmel Galvin disposed of 30,541 shares to satisfy tax obligations related to RSU vesting.

Klaviyo CFO Amanda Whalen reported the conversion and sale of Series B common stock into Series A common stock pursuant to a pre-established Rule 10b5-1 trading plan.

Klaviyo Co-CEO Andrew Bialecki sold 200,000 shares of Series A Common Stock pursuant to a pre-established Rule 10b5-1 trading plan.

Klaviyo Chief Legal Officer Landon Edmond sold 9,623 shares of common stock pursuant to a pre-established 10b5-1 trading plan.

Klaviyo Chief Legal Officer Landon Edmond was granted 151,515 restricted stock units and 129,870 performance stock units.

Klaviyo Chief People Officer Carmel Galvin was granted 189,393 restricted stock units and 162,337 performance stock units.

Klaviyo CFO Amanda Whalen was granted restricted and performance-based stock units and executed a planned sale of common stock.

Klaviyo Co-CEO Andrew Bialecki sold 200,000 shares of Series A Common Stock pursuant to a pre-arranged Rule 10b5-1 trading plan.

Klaviyo Co-Chief Executive Andrew Bialecki reported the sale of 200,000 shares of Series A Common Stock for $18.63 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Klaviyo Co-CEO Andrew Bialecki sold 200,000 shares of Series A Common Stock for approximately $19.42 per share, totaling $3.88 million, as part of a pre-arranged trading plan.

Klaviyo Co-CEO Andrew Bialecki sold 200,000 shares of Series A Common Stock for a weighted average price of $18.17 per share, executed under a pre-arranged 10b5-1 trading plan.

Klaviyo Co-Chief Executive Officer Andrew Bialecki has filed a Form 4 detailing planned conversions and sales of Series A Common Stock under a Rule 10b5-1 trading plan.

Klaviyo's Chief Legal Officer, Landon Edmond, sold 14,366 shares of Series A Common Stock for a weighted average price of $20.15 per share under a pre-arranged 10b5-1 trading plan.

Klaviyo's Chief Financial Officer, Amanda Whalen, sold 14,000 shares of Series A Common Stock on March 12, 2026, as part of a pre-arranged Rule 10b5-1 trading plan.

Klaviyo's Co-Chief Executive Officer, Andrew Bialecki, executed pre-planned sales of Series A Common Stock totaling 206,827 shares on March 10, 2026, following a conversion from Series B shares.

Klaviyo's Chief Legal Officer, Landon Edmond, filed a Form 4 disclosing a planned sale of 15,093 shares of Series A Common Stock in March 2026 under a pre-arranged 10b5-1 trading plan.

Klaviyo Co-CEO Andrew Bialecki sold 200,000 shares of Series A Common Stock for approximately $3.7 million through a pre-arranged 10b5-1 trading plan.